Wuhan
688526.SSWuhan Keqian Biology Co.,Ltd Price (688526.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
465,805,821
(0.0954)%Revenue and Profitability
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 390,397,645 | 632,834,936 | 735,300,094 | 507,511,164 | 843,227,687 | 1,103,021,004 | 1,001,267,679 | 1,064,074,588 |
| Net Income | 186,157,716 | 320,318,155 | 388,969,369 | 242,642,486 | 447,803,050 | 570,741,302 | 409,518,439 | 395,934,947 |
| FCF USD | 191,563,155 | 208,497,966 | 320,413,263 | 17,152,731 | 288,540,982 | 156,824,416 | 320,857,683 | 433,529,737 |
| OCF USD | 220,692,785 | 337,611,846 | 351,834,753 | 154,888,411 | 400,136,846 | 531,270,020 | 423,708,722 | 538,033,925 |
Financial Health - DEBT
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.36 | 0.01 |
| D/E | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 | 0.08 | 0.08 |
| CA/CL | 2.71 | 2.81 | 2.89 | 4.11 | 6.95 | 3.58 | 4.11 | 3.38 |
| TA/TL | 3.31 | 3.60 | 3.48 | 5.43 | 7.73 | 6.52 | 4.92 | 5.60 |
| Total Debt | 0 | 2,550,000 | 0 | 0 | 60,057,925 | 78,092,652 | 279,482,211 | 293,508,905 |
Management Performance
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| ROIC | 40.22% | 44.87% | 42.27% | 20.90% | 16.04% | 17.26% | 10.50% | 9.45% |
| ROE | 45.10% | 47.59% | 44.39% | 21.68% | 16.53% | 18.10% | 11.71% | 10.32% |
| ROA | 0.00% | 34.36% | 31.62% | 17.69% | 14.39% | 15.32% | 9.32% | 8.47% |
| NM % | 47.68% | 50.62% | 52.90% | 47.81% | 53.11% | 51.74% | 40.90% | 37.21% |
| FCF / R% | 0.00% | 32.95% | 43.58% | 3.38% | 34.22% | 14.22% | 32.05% | 40.74% |
| FCF / NI% | 102.90% | 65.09% | 82.39% | 7.07% | 64.43% | 27.48% | 78.42% | 109.59% |
| Operating Margin (OM) | 0.00 | 0.74 | 0.47 | 1.11 | 1.15 | 1.22 | 1.63 | 1.82 |
Per Share
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EPS | 0.52 | 0.89 | 1.08 | 0.52 | 0.96 | 1.23 | 0.88 | 0.85 |
| SPS | 1.09 | 1.76 | 2.04 | 1.09 | 1.81 | 2.37 | 2.15 | 2.28 |
| OCPS | 0.62 | 0.94 | 0.98 | 0.33 | 0.86 | 1.14 | 0.91 | 1.16 |
| FCPS | 0.54 | 0.58 | 0.89 | 0.04 | 0.62 | 0.34 | 0.69 | 0.93 |
| BVPS | 1.15 | 1.87 | 2.43 | 2.41 | 5.82 | 6.78 | 7.52 | 8.24 |
Per Share - CAGR
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.52 | 0.89 | 1.08 | 0.52 | 0.96 | 1.23 | 0.88 | 0.85 |
| CAGR-SPS | 1.09 | 1.76 | 2.04 | 1.09 | 1.81 | 2.37 | 2.15 | 2.28 |
| CAGR-OCPS | 0.62 | 0.94 | 0.98 | 0.33 | 0.86 | 1.14 | 0.91 | 1.16 |
| CAGR-FCPS | 0.54 | 0.58 | 0.89 | 0.04 | 0.62 | 0.34 | 0.69 | 0.93 |
| CAGR-BVPS | 1.15 | 1.87 | 2.43 | 2.41 | 5.82 | 6.78 | 7.52 | 8.24 |